If patients have a severe obesity-related complication including but not limited to hypertension, type 2 diabetes, CVD, dyslipidemia and a BMI of 27 mg/kg 2 or greater, then concurrent initiation of weight-loss medication with lifestyle interventions can be considered, according to the guideline
Liu H, Sridhar VS, Perkins BA, Rosenstock J, Cherney DZI (2022) SGLT2 inhibition in type 1 diabetes with diabetic kidney disease: potential cardiorenal benefits can outweigh preventable risk of diabetic ketoacidosis
Teladoc Health $99-$299 NovoCare Pharmacy NovoCare Pharmacy launched in 2023 as Novo Nordisk's direct-to-patient pharmacy channel a manufacturer-operated service that allows patients to obtain brand-name Wegovy and Ozempic directly from
Pandey A, Khan MS, Patel KV, Bhatt DL, Verma S